Picture
On Monday afternoon, the National Cancer Institute released its Annual Report to the Nation on the Status of Cancer, the most comprehensive and detailed report of its kind with regard to cancer trends.

This year's report shows that "overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate." On the rise? Melanoma of the skin (among men only) and for cancers of the liver, pancreas, and uterus.

The report, produced since 1998, is co-authored by researchers from the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR). It appears online in the Journal of the National Cancer Institute.

This year's report also featured "special feature section on human papillomavirus (HPV)-associated cancers," which showed that "incidence rates are increasing for HPV-associated oropharyngeal and anal cancers and that vaccination coverage levels in the U.S. during 2008 and 2010 remained low among adolescent girls."

“The continuing drop in cancer mortality over the past two decades is reason to cheer,” said John R. Seffrin, Ph.D., chief executive officer of the American Cancer Society. “The challenge we now face is how to continue those gains in the face of new obstacles, like obesity and HPV infections. We must face these hurdles head on, without distraction, and without delay, by expanding access to proven strategies to prevent and control cancer.”

Click "Read More" to view a PDF of the full report, as well as a comprehensive Q&A document detailing the report's methodology.

• Report to the Nation shows U.S. cancer death rates continue to drop; Special feature highlights trends in HPV-associated cancers and HPV vaccination coverage levels (Cancer.gov, Jan. 7, 2013)

 


Comments


Your comment will be posted after it is approved.


Leave a Reply